OCE Conversations on Cancer – More Isn’t Always Better: Understanding Cancer Treatment Tolerability

The event will address understanding tolerability in the context of current cancer treatments. This panel discussion will feature a diverse group of speakers, including patients, clinicians, researchers, and FDA representatives to share their unique perspectives. The speakers will discuss the importance and integration of the patient experience in evaluating tolerability (for example, through use of patient-reported outcome measures), clinician consideration of patient-reported tolerability, the impact of tolerability on treatment decisions, and dose optimization.